Tetra-aryl cyclobutane inhibitors of androgen receptor action for the treatment of hormone refractory cancer

摘要

The present disclosure provides tetra-substituted cyclobutane inhibitors of Androgen Receptor Action, and methods of using such inhibitors, for the treatment of hormone-refractory cancers.